(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
To compare the presence of post-operative residual disease by magnetic resonance imaging (MRI) and [18F]fluorothymidine (FLT)-positron emission tomography (PET)-computer tomography (CT) in patients with malignant glioma and to estimate the impact of 18F-FLT PET on the delineation of post-operative t...
Main Authors: | Fen Zhao, Minghuan Li, Zhiheng Wang, Zheng Fu, Yunfeng Cui, Zhaoqiu Chen, Jinming Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4349865?pdf=render |
Similar Items
-
Pilot study assessing 18F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation
by: Linda P. Cho, et al.
Published: (2015-11-01) -
Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
by: Tomoya Ogawa, et al.
Published: (2020-05-01) -
The Value of Glioma Extent of Resection in the Modern Neurosurgical Era
by: Douglas A Hardesty, et al.
Published: (2012-10-01) -
Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
by: Alexandra Nikaki, et al.
Published: (2019-01-01) -
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
by: Peter K. Wong, et al.
Published: (2014-05-01)